Avalyn Pharma Inc. Common Stock (AVLN) vs Omada Health (OMDA)
A side-by-side comparison of Avalyn Pharma Inc. Common Stock and Omada Health across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AVLN
Avalyn Pharma Inc. Common Stock
$25.66HealthcareDelayed quote: Oct 6, 2026, 12:30 PM EDT
OMDA
Omada Health
$20.61HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
Total return — AVLN vs OMDA
growth of $100 · dividends reinvested · last 1yAVLN -8.3% (-8.3%/yr)OMDA +43.7% (+43.7%/yr)OMDA compounded faster over this window
AVLN OMDA
AVLN vs OMDA: by the numbers
- •OMDA is the larger company ($1.23B vs $1.14B market cap).
- •OMDA is profitable (1.39% net margin) while AVLN runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | AVLN | OMDA |
|---|---|---|
| P/E ratio | N/A | 327.19 |
| P/S ratio | N/A | 3.96 |
| P/B ratio | 2.86 | 4.85 |
| EV / EBITDA | N/A | 144.65 |
| FCF yield | N/A | 1.64% |
Profitability
| Metric | AVLN | OMDA |
|---|---|---|
| Gross margin | 0.00% | 68.19% |
| Operating margin | 0.00% | -0.15% |
| Net margin | 0.00% | 1.39% |
| ROE | N/A | 1.70% |
| ROIC | -67.73% | -0.18% |
Frequently asked
- Is AVLN or OMDA more profitable?
- OMDA runs the higher net margin — AVLN at 0.00% versus OMDA at 1.39%.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.